JPH092976A - Coating composition - Google Patents
Coating compositionInfo
- Publication number
- JPH092976A JPH092976A JP7176707A JP17670795A JPH092976A JP H092976 A JPH092976 A JP H092976A JP 7176707 A JP7176707 A JP 7176707A JP 17670795 A JP17670795 A JP 17670795A JP H092976 A JPH092976 A JP H092976A
- Authority
- JP
- Japan
- Prior art keywords
- coating
- coating composition
- tablets
- inorganic substance
- polyvinylpyrrolidone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008199 coating composition Substances 0.000 title claims abstract description 83
- 239000011248 coating agent Substances 0.000 claims abstract description 75
- 238000000576 coating method Methods 0.000 claims abstract description 58
- 239000000126 substance Substances 0.000 claims abstract description 31
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 25
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 25
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 25
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 17
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 17
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 6
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000454 talc Substances 0.000 claims abstract description 5
- 229910052623 talc Inorganic materials 0.000 claims abstract description 5
- 229920001800 Shellac Polymers 0.000 claims abstract description 4
- 229940024546 aluminum hydroxide gel Drugs 0.000 claims abstract description 4
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 claims abstract description 4
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 claims abstract description 4
- XLIDPNGFCHXNGX-UHFFFAOYSA-N dialuminum;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Si+4] XLIDPNGFCHXNGX-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960001545 hydrotalcite Drugs 0.000 claims abstract description 4
- 229910001701 hydrotalcite Inorganic materials 0.000 claims abstract description 4
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims abstract description 4
- 239000001095 magnesium carbonate Substances 0.000 claims abstract description 4
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims abstract description 4
- 239000000395 magnesium oxide Substances 0.000 claims abstract description 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims abstract description 4
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000004208 shellac Substances 0.000 claims abstract description 4
- 235000013874 shellac Nutrition 0.000 claims abstract description 4
- 229940113147 shellac Drugs 0.000 claims abstract description 4
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims abstract description 4
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 3
- 150000004676 glycans Chemical class 0.000 claims abstract description 3
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 3
- 239000005017 polysaccharide Substances 0.000 claims abstract description 3
- 239000000463 material Substances 0.000 claims 4
- 239000008187 granular material Substances 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 7
- 229920002678 cellulose Polymers 0.000 abstract description 6
- 239000001913 cellulose Substances 0.000 abstract description 6
- 239000003826 tablet Substances 0.000 description 47
- 239000006185 dispersion Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 14
- 238000007796 conventional method Methods 0.000 description 13
- 239000003814 drug Substances 0.000 description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 7
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 7
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 7
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 7
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 7
- 229960005489 paracetamol Drugs 0.000 description 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 239000001856 Ethyl cellulose Substances 0.000 description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 4
- 235000019325 ethyl cellulose Nutrition 0.000 description 4
- 229920001249 ethyl cellulose Polymers 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 238000007127 saponification reaction Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- -1 carboxymethyl ethyl Chemical group 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 229920003144 amino alkyl methacrylate copolymer Polymers 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 description 2
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 2
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000019596 Masking bitterness Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000007894 caplet Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- JAUGGEIKQIHSMF-UHFFFAOYSA-N dialuminum;dimagnesium;dioxido(oxo)silane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O JAUGGEIKQIHSMF-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000005243 fluidization Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
(57)【要約】
【構成】 酸化チタン、タルク、酸化マグネシウム、炭
酸カルシウム、炭酸マグネシウム、二酸化ケイ素、無水
ケイ酸、ケイ酸アルミニウム、合成ヒドロタルサイト及
び乾燥水酸化アルミニウムゲルから選ばれる1種又は2
種以上の無機物質と、セルロース系被覆剤、アクリル系
被覆剤、多糖類系被覆剤及びセラックから選ばれる1種
又は2種以上の被覆剤と、ポリビニルピロリドン及び/
又はポリビニルアルコールとを含有してなることを特徴
とする被覆組成物。
【効果】 無機物質を含有する被覆組成物により錠剤又
は粒状物を被覆する際に、被覆後の錠剤又は粒状物の汚
れを防止し、高品質の被覆物を効率的に製造できる。無
機物質の配合量は、汚れによる制約を受けることなく、
任意に設定することができる。(57) [Summary] [Structure] One selected from titanium oxide, talc, magnesium oxide, calcium carbonate, magnesium carbonate, silicon dioxide, silicic acid anhydride, aluminum silicate, synthetic hydrotalcite and dry aluminum hydroxide gel or Two
At least one inorganic substance, at least one selected from cellulose-based coating agents, acrylic coating agents, polysaccharide-based coating agents and shellac, and polyvinylpyrrolidone and / or
Alternatively, a coating composition comprising polyvinyl alcohol. [Effects] When coating tablets or granules with a coating composition containing an inorganic substance, stains of the tablets or granules after coating can be prevented, and a high-quality coating can be efficiently produced. The blending amount of inorganic substances is not restricted by dirt,
It can be set arbitrarily.
Description
【0001】[0001]
【産業上の利用分野】本発明は、無機物質を含有する被
覆組成物に関し、特に錠剤又は粒状物を被覆する際に、
錠剤又は粒状物が汚れることを防止した被覆組成物に関
する。FIELD OF THE INVENTION The present invention relates to a coating composition containing an inorganic substance, and more particularly to coating a tablet or granules.
The present invention relates to a coating composition which prevents tablets or granules from becoming soiled.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】錠剤又
は粒状物については、その苦み等のマスキング、服用性
の向上、外観の美麗化などを図る方法としてこれらに被
覆を施す方法が採用されている。また、錠剤又は粒状物
自体が色を有する場合、それらの色の隠蔽やその他の理
由により、顔料として無機物質を添加した被覆組成物を
利用することがある。例えば、酸化チタン等の高屈折率
を有する無機物質を添加した被覆組成物は、被覆膜中の
上記無機物質が透過光を遮断することを利用し、光に不
安定な薬物を安定化したり、薬物特有の色の隠蔽や固形
製剤の表面を美麗化するために使用されている。さら
に、被覆組成物に無機物質を添加することにより、被覆
操作中の被覆組成物の被覆性を高める展延効果、及びコ
ーティング機と固形製剤、又は固形製剤と固形製剤との
摩擦を低減する滑沢効果が得られ、無機物質は被覆組成
物のコーティング適性を向上させるという役割も果たし
ている。2. Description of the Related Art For tablets or granules, a method of coating these tablets or granules is used as a method for masking bitterness and the like, improving ingestibility, and improving the appearance. There is. Further, when the tablet or the granular material itself has a color, a coating composition to which an inorganic substance is added as a pigment may be used for the reason of hiding the color or other reasons. For example, a coating composition to which an inorganic substance having a high refractive index such as titanium oxide is added utilizes the fact that the inorganic substance in the coating film blocks transmitted light, and stabilizes a drug that is unstable to light. It is used to hide the color peculiar to drugs and to beautify the surface of solid preparations. Furthermore, by adding an inorganic substance to the coating composition, a spreading effect that enhances the coating property of the coating composition during the coating operation, and a sliding agent that reduces friction between the coating machine and the solid formulation or the solid formulation and the solid formulation are obtained. The effect is obtained, and the inorganic substance also plays the role of improving the coating suitability of the coating composition.
【0003】しかしながら、顔料として使用される無機
物質には、比較的硬度の高いものがあり、そのため被覆
操作中や被覆操作後に、これらの無機物質が被覆・輸送
装置等に接触し、その接触面の摩耗等により汚れが生
じ、この汚れが被覆処理後の錠剤や粒状物の表面に付着
し、それらの商品価値を著しく損なうという事態が生じ
ている。このような事態を防ぐために、被覆組成物に添
加する無機物質(顔料)の配合量を減量すると共に、そ
の被覆量を増加する方法、又はポリエチレングリコール
(槙野ら,薬剤学,Vol.54,No.1,199
4)やその他の滑沢効果を有する添加剤を被覆組成物に
加える方法等が提案されているが、無機物質の配合量を
減量する方法の場合、被覆量の増加によって崩壊時間の
遅延化や工程時間の延長を招き、一方、ポリエチレング
リコール等を添加する方法の場合、一般的な被覆組成物
の組成であってもポリエチレングリコール等を添加でき
ない組成があり、実質的に上記問題を解決するには至っ
ていない。However, some inorganic substances used as pigments have a relatively high hardness. Therefore, these inorganic substances come into contact with a coating / transporting device or the like during or after the coating operation, and the contact surface thereof. There is a situation in which stains are generated due to abrasion and the like, and the stains adhere to the surfaces of the tablets and granules after the coating treatment, which significantly impairs their commercial value. In order to prevent such a situation, the amount of the inorganic substance (pigment) added to the coating composition is reduced and the amount of the coating is increased, or polyethylene glycol (Makino et al., Pharmaceutical Science, Vol. 54, No. .1,199
4) and other additives having a lubricating effect are added to the coating composition, but in the case of a method of reducing the compounding amount of the inorganic substance, the disintegration time is delayed or increased due to the increase of the coating amount. On the other hand, in the case of the method of adding polyethylene glycol or the like, which prolongs the process time, there is a composition in which polyethylene glycol or the like cannot be added even if it is a composition of a general coating composition. Has not arrived.
【0004】本発明は上記事情に鑑みなされたもので、
無機物質を含有する被覆組成物により錠剤又は粒状物を
被覆するにあたり、被覆後の錠剤又は粒状物に汚れが付
着することを防止する被覆組成物を提供することを目的
とするものである。[0004] The present invention has been made in view of the above circumstances,
It is an object of the present invention to provide a coating composition for preventing stains from adhering to the coated tablets or granules when coating the tablets or granules with the coating composition containing an inorganic substance.
【0005】[0005]
【課題を解決するための手段及び作用】本発明者らは、
上記目的を達成するため鋭意研究を重ねた結果、無機物
質を含有する被覆組成物に特定の高分子化合物、即ちポ
リビニルピロリドンやポリビニルアルコールを配合する
ことにより、被覆後の錠剤又は粒状物の汚れを防止でき
ることを見い出し、本発明をなすに至った。Means and Action for Solving the Problems The present inventors have
As a result of intensive studies to achieve the above object, a specific polymer compound, that is, polyvinylpyrrolidone or polyvinyl alcohol, is added to a coating composition containing an inorganic substance, whereby stains of tablets or granules after coating are prevented. The inventors have found that they can be prevented and have completed the present invention.
【0006】即ち、本発明は、無機物質と被覆剤とポリ
ビニルピロリドン及び/又はポリビニルアルコールとを
含有してなることを特徴とする被覆組成物を提供する。That is, the present invention provides a coating composition comprising an inorganic substance, a coating agent and polyvinylpyrrolidone and / or polyvinyl alcohol.
【0007】以下、本発明を更に詳述すると、本発明の
被覆組成物は、無機物質と被覆剤とポリビニルピロリド
ン及び/又はポリビニルアルコールとを必須成分とする
ものである。ここで、本発明の無機物質としては、公知
の被覆組成物に一般的に添加されているものを使用する
ことができるが、そのような無機物質として、例えば酸
化チタン、タルク、酸化マグネシウム、炭酸カルシウ
ム、炭酸マグネシウム、二酸化ケイ素、無水ケイ酸、ケ
イ酸アルミニウム、合成ヒドロタルサイト、乾燥水酸化
アルミニウムゲル、ケイ酸マグネシウム、メタケイ酸ア
ルミン酸マグネシウムなどを挙げることができ、これら
はその1種を単独で、又は2種以上を併用して使用する
ことができる。これらの中でも特に酸化チタン、タル
ク、酸化マグネシウム、炭酸カルシウム、炭酸マグネシ
ウム、二酸化ケイ素、無水ケイ酸、ケイ酸アルミニウ
ム、合成ヒドロタルサイト及び乾燥水酸化アルミニウム
ゲルから選ばれる1種又は2種以上の組合せが好適であ
る。The present invention will be described in more detail below. The coating composition of the present invention contains an inorganic substance, a coating agent, polyvinylpyrrolidone and / or polyvinyl alcohol as essential components. Here, as the inorganic substance of the present invention, those generally added to known coating compositions can be used. Examples of such inorganic substances include titanium oxide, talc, magnesium oxide, and carbonic acid. Calcium, magnesium carbonate, silicon dioxide, anhydrous silicic acid, aluminum silicate, synthetic hydrotalcite, dry aluminum hydroxide gel, magnesium silicate, magnesium aluminometasilicate, etc. may be mentioned, and one of them may be used alone. , Or two or more kinds can be used in combination. Among these, in particular, one or a combination of two or more selected from titanium oxide, talc, magnesium oxide, calcium carbonate, magnesium carbonate, silicon dioxide, silicic acid anhydride, aluminum silicate, synthetic hydrotalcite and dry aluminum hydroxide gel. Is preferred.
【0008】本発明の被覆組成物における上記無機物質
の配合量は、被覆目的により任意に調整することができ
るが、被覆組成物全体(被覆操作後形成された溶媒を含
まないもの、以下同様)の0.1〜50%(重量%、以
下同様)、特に1〜25%とすると好適である。0.1
%未満では実質的にその配合意義が消失される場合があ
り、50%を超えると被覆物の強度が低下し脆弱とな
り、商品価値を損う場合がある。The blending amount of the above-mentioned inorganic substance in the coating composition of the present invention can be arbitrarily adjusted according to the purpose of coating, but the entire coating composition (the one containing no solvent formed after the coating operation, the same applies hereinafter). 0.1 to 50% (% by weight, the same applies hereinafter), and particularly preferably 1 to 25%. 0.1
If it is less than%, the significance of its blending may be substantially lost, and if it exceeds 50%, the strength of the coated article may be reduced to make it brittle, and the commercial value may be impaired.
【0009】本発明の被覆剤としては、公知の被覆組成
物に一般的に添加されているものを使用することができ
るが、そのような被覆剤として、例えばセルロース系、
アクリル系、多糖類系被覆剤やセラック等が好適に使用
され、より具体的には、メチルセルロース、エチルセル
ロース、ヒドロキシプロピルセルロース、ヒドロキシプ
ロピルメチルセルロース、ヒドロキシプロピルメチルセ
ルロースフタレート、ヒドロキシプロピルメチルセルロ
ースアセテートサクシネート、ポリビニルアセタールジ
エチルアミノアセテート、カルボキシメチルエチルセル
ロース、酢酸フタル酸セルロース、デキストリン、プル
ラン、アミノアルキルメタアクリレートコポリマー、メ
タアクリル酸コポリマー、アルギン酸ナトリウム、セラ
ック、アラビアゴム末、白糖、マンニトール、ゼラチン
等が好適に使用され、これらはその1種を単独で、又は
2種以上を併用して使用することができるが、これらの
中でも、特にヒドロキシプロピルメチルセルロース、エ
チルセルロース、ヒドロキシプロピルセルロース、ヒド
ロキシプロピルメチルセルロースアセテートサクシネー
ト、アミノアルキルメタアクリレートコポリマー、メタ
アクリル酸コポリマー等がより好適に使用される。As the coating agent of the present invention, those generally added to known coating compositions can be used. Examples of such coating agents include cellulosics,
Acrylic-based, polysaccharide-based coating agents and shellac are preferably used, and more specifically, methylcellulose, ethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxypropylmethylcellulose phthalate, hydroxypropylmethylcellulose acetate succinate, polyvinyl acetal diethylamino. Acetate, carboxymethyl ethyl cellulose, cellulose acetate phthalate, dextrin, pullulan, aminoalkyl methacrylate copolymer, methacrylic acid copolymer, sodium alginate, shellac, gum arabic powder, sucrose, mannitol, gelatin and the like are preferably used. One kind may be used alone, or two or more kinds may be used in combination. Hydroxypropyl methylcellulose, ethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose acetate succinate, aminoalkyl methacrylate copolymer, methacrylic acid copolymer and the like are more preferably used.
【0010】本発明の被覆組成物における上記被覆剤の
配合量は、被覆目的により任意に調整することができる
が、組成物全体の10〜98%、特に50〜95%とす
ると好適である。10%未満では錠剤又は粒状物に対し
十分に被覆されないことがあり、98%を超えると被覆
剤を通しての薬物の溶出が著しく遅延し、薬物の生物学
的利用率が低下して、商品価値を損う場合がある。The blending amount of the above-mentioned coating agent in the coating composition of the present invention can be arbitrarily adjusted depending on the purpose of coating, but it is preferably 10 to 98%, particularly 50 to 95% of the total composition. If it is less than 10%, it may not be sufficiently coated on tablets or granules, and if it exceeds 98%, the elution of the drug through the coating agent may be significantly delayed, and the bioavailability of the drug may be lowered, thus reducing the commercial value. It may be damaged.
【0011】本発明の被覆組成物は、上記被覆剤を配合
することにより、被覆膜の吸湿防止(防湿性)、薬剤の
不快な味,臭いの隠蔽,食道への通過(すべり)の改良
等による薬物の服用性の改善、空気酸化防止等による薬
剤の安定化、薬剤の徐放性(効果の持続性付与),放出
部位(胃、腸等)のコントロール等による薬物の放出制
御などを可能とするものである。The coating composition of the present invention contains the above coating agent to improve the prevention of moisture absorption of the coating film (moisture resistance), the unpleasant taste of the drug, the masking of odor, and the passage (slip) to the esophagus. Etc. to improve the drug taking ability, stabilize the drug by preventing air oxidation, etc., control the release of the drug by controlling the release site (stomach, intestine, etc.), etc. It is possible.
【0012】本発明の被覆組成物は、上記無機物質と被
覆剤とに加え、更にポリビニルピロリドン及び/又はポ
リビニルアルコールを配合するものであるが、ポリビニ
ルピロリドンやポリビニルアルコールは、被覆剤として
用いられることもある。しかし、ポリビニルピロリドン
は粘着性と曳糸性が強く、ポリビニルアルコールは造膜
性(特に薄膜化)が低いので、いずれも被覆剤としての
適性には乏しい。そのため、本発明の被覆組成物はポリ
ビニルピロリドンやポリビニルアルコールを被覆剤とし
てではなく、組成物中の無機物質と被覆・輸送装置等と
の摩擦等を防止するものとして配合するものである。The coating composition of the present invention contains polyvinylpyrrolidone and / or polyvinyl alcohol in addition to the above-mentioned inorganic substance and coating agent. Polyvinylpyrrolidone and polyvinyl alcohol should be used as a coating agent. There is also. However, since polyvinylpyrrolidone has strong adhesiveness and spinnability, and polyvinyl alcohol has low film-forming property (especially thin film), they are not suitable as coating agents. Therefore, the coating composition of the present invention does not contain polyvinylpyrrolidone or polyvinyl alcohol as a coating agent, but as a composition for preventing friction between the inorganic substance in the composition and the coating / transporting device.
【0013】本発明のポリビニルピロリドンは、種々の
分子量のものを選択することができるが、重量平均分子
量が10,000〜1,200,000、特に25,0
00〜40,000のものが好適である。10,000
未満では被覆組成物の粘着性が増強され、組成物のハン
ドリングに問題を生じることがあり、1,200,00
0を超えると他の成分との相溶性が悪化し、安定な被覆
物を調製することが難しくなる場合がある。The polyvinylpyrrolidone of the present invention can be selected from those having various molecular weights, but the weight average molecular weight thereof is 10,000 to 1,200,000, particularly 25.0.
Those of 00 to 40,000 are preferable. 10,000
If it is less than 1, the coating composition may have increased tackiness, which may cause problems in handling the composition.
If it exceeds 0, the compatibility with other components is deteriorated, and it may be difficult to prepare a stable coating.
【0014】本発明の被覆組成物におけるポリビニルピ
ロリドンの配合量は、特に制限されるものではないが、
上記無機物質に対し5〜5000%、特に10〜250
0%とすると好適である。5%未満では被覆組成物表面
の汚れに対し、十分な抑制効果が期待できないことがあ
り、5000%を超えると粘着性が過大となり、実質的
に造膜性を低下させ、製造上困難を来たす場合がある。
また、同様の理由により、被覆組成物全体の0.5〜5
0%、特に1〜20%とすると好適である。The blending amount of polyvinylpyrrolidone in the coating composition of the present invention is not particularly limited,
5 to 5000%, especially 10 to 250, relative to the above inorganic substances
It is preferably 0%. If it is less than 5%, a sufficient effect of suppressing stains on the surface of the coating composition may not be expected, and if it exceeds 5000%, the tackiness becomes excessive, which substantially lowers the film-forming property and causes manufacturing difficulties. There are cases.
Further, for the same reason, 0.5 to 5% of the entire coating composition is used.
It is preferably 0%, especially 1 to 20%.
【0015】本発明のポリビニルアルコールは、種々の
けん化度のものを選択することができるが、被覆組成物
の分散に使用可能な溶媒に対する溶解度を考慮すれば、
そのけん化度は60〜100モル%、特に78〜96モ
ル%であることが好ましい。60モル%未満では接着性
が過大となり、実質的に造膜性を低下させ、製造上困難
を来たす場合がある。また、その重合度も特に制限され
るものではないが、被覆操作に適当な分散性を有する重
合度を選択することが好ましく、その重合度は300〜
3,000とすると好適である。300未満ではベタツ
キが生じる場合があり、3,000を超えると粘性に悪
影響を及ぼす場合がある。The polyvinyl alcohol of the present invention can be selected from those having various degrees of saponification, but considering the solubility in a solvent usable for dispersing the coating composition,
The degree of saponification is preferably 60 to 100 mol%, particularly 78 to 96 mol%. If it is less than 60 mol%, the adhesiveness will be excessive and the film-forming property will be substantially deteriorated, which may cause difficulty in production. The degree of polymerization is not particularly limited, but it is preferable to select a degree of polymerization having a dispersibility suitable for the coating operation, and the degree of polymerization is 300 to
A value of 3,000 is suitable. If it is less than 300, stickiness may occur, and if it exceeds 3,000, the viscosity may be adversely affected.
【0016】本発明の被覆組成物におけるポリビニルア
ルコールの配合量は、特に制限されるものではないが、
上記無機物質に対し5〜5000%、特に10〜250
0%とすると好適である。5%未満では被覆組成物表面
の汚れに対し、十分な抑制効果が期待できないことがあ
り、5000%を超えると接着性が過大となり、実質的
に造膜性を低下させ、製造上困難を来たす場合がある。
また、同様の理由により、被覆組成物全体の0.5〜5
0%、特に1〜20%とすると好適である。The blending amount of polyvinyl alcohol in the coating composition of the present invention is not particularly limited,
5 to 5000%, especially 10 to 250, relative to the above inorganic substances
It is preferably 0%. If it is less than 5%, a sufficient effect of suppressing the stain on the surface of the coating composition may not be expected, and if it exceeds 5000%, the adhesiveness becomes excessively large, and the film-forming property is substantially lowered, which causes difficulty in production. There are cases.
Further, for the same reason, 0.5 to 5% of the entire coating composition is used.
It is preferably 0%, especially 1 to 20%.
【0017】本発明の被覆組成物の調製方法は、特に制
限されるものではなく、例えばその被覆操作に際し、被
覆組成物の各成分を適当な溶媒に分散又は溶解させて使
用すればよく、このような溶媒としては、ポリビニルピ
ロリドン及び/又はポリビニルアルコールを溶解し、且
つ上記被覆剤を溶解又は分散するものが好適であり、例
えば水やメタノール,エタノール,エーテル,アセト
ン,イソプロパノール等の有機溶媒などを挙げることが
でき、これらを1種単独で、又は2種以上を組み合わせ
た混合溶媒として使用しても差し支えない。ここで、被
覆操作時に使用される被覆組成物の分散溶液の調製方法
も特に限定されるものではなく、常法により例えばホモ
ミキサー等の分散機器を用いて調製することができるほ
か、一般のプロペラ型撹拌機器のみを用いて調製しても
本発明の効果を発現させることができる。The method for preparing the coating composition of the present invention is not particularly limited, and for example, during the coating operation, each component of the coating composition may be dispersed or dissolved in a suitable solvent before use. As such a solvent, one that dissolves polyvinylpyrrolidone and / or polyvinyl alcohol, and dissolves or disperses the above-mentioned coating agent is preferable, and for example, water or an organic solvent such as methanol, ethanol, ether, acetone, or isopropanol. These may be mentioned, and these may be used alone or as a mixed solvent in which two or more thereof are combined. Here, the method for preparing the dispersion solution of the coating composition used in the coating operation is not particularly limited, and it can be prepared by a conventional method using a dispersing machine such as a homomixer, and a general propeller. The effect of the present invention can be exhibited even when prepared using only a mold stirring device.
【0018】本発明の被覆組成物は、本発明の効果を妨
げない範囲で必要に応じて、適宜他の添加剤を加えるこ
とができ、このような添加剤として、例えばポリエチレ
ングリコール、プロピレングリコール、グリセリン、シ
クロデキストリン、ステアリン酸及びその塩、ゼラチ
ン、アラビアゴム末、カルナウバロウ、白糖、クエン酸
トリアルキル、ショ糖脂肪酸エステル、グリセリン脂肪
酸エステル、シリコーン樹脂、ポリソルベート、着香
料、着色剤、矯味剤等を挙げることができる。The coating composition of the present invention may optionally contain other additives as necessary within the range not impairing the effects of the present invention. Examples of such additives include polyethylene glycol, propylene glycol, Glycerin, cyclodextrin, stearic acid and its salts, gelatin, gum arabic powder, carnauba wax, sucrose, trialkyl citrate, sucrose fatty acid ester, glycerin fatty acid ester, silicone resin, polysorbate, flavoring agent, coloring agent, flavoring agent, etc. Can be mentioned.
【0019】本発明の被覆組成物により被覆される錠剤
又は粒状物は、特にその種類が制限されるものではない
が、無機物質を配合する理由を鑑みれば、種々の生理活
性を有する物質や賦形剤等を適宜含有する医薬品や化粧
品が好適である。これらの錠剤や粒状物は、その形状及
び破壊強度等も任意であり、特に制限されるものではな
いが、常法による被覆操作の完遂に耐えうる形状および
破壊強度を有していることが好ましい。The type of the tablet or granule coated with the coating composition of the present invention is not particularly limited, but in view of the reason for incorporating an inorganic substance, a substance or excipient having various physiological activities is provided. Pharmaceuticals and cosmetics, which appropriately contain excipients and the like, are suitable. The shape and breaking strength of these tablets and granules are not particularly limited and are not particularly limited, but it is preferable that they have a shape and breaking strength capable of withstanding the completion of the coating operation by a conventional method. .
【0020】本発明の被覆組成物のこれらの錠剤や粒状
物に対する被覆量(割合)は、錠剤や粒状物の形状や被
覆目的によって異なるため一概にはいえないが、一般に
0.5%以上、特に1%以上が好適である。このような
被覆量は、特にその上限が限定されるものではないが、
作業効率、コスト等を考慮すれば、被覆目的を満足でき
る量以上であり、且つできるだけ少ない量であることが
好ましい。The coating amount (ratio) of the coating composition of the present invention to these tablets and granules varies depending on the shape of the tablets and granules and the purpose of coating, but it cannot be generally stated, but generally 0.5% or more, Particularly, 1% or more is preferable. Such a coating amount is not particularly limited in its upper limit,
Considering work efficiency, cost, etc., it is preferable that the amount is equal to or more than the amount that can satisfy the purpose of coating, and as small as possible.
【0021】本発明の被覆組成物の被覆方法は特に限定
されるものではなく、例えば常法により錠剤や粒状物の
表面に上記分散溶液をスプレーして被覆する方法等が採
用できる。このようにして被覆された粒状物は、例えば
賦形剤等を加えて顆粒剤とすることができ、更に常法に
より賦形剤等を加えて錠剤とすることもできる。The method of coating the coating composition of the present invention is not particularly limited, and for example, a method of spraying the above-mentioned dispersion solution on the surface of tablets or granules by a conventional method and the like can be employed. The granular material coated in this manner can be made into granules by adding, for example, an excipient or the like, and can also be made into tablets by adding an excipient or the like by a conventional method.
【0022】[0022]
【発明の効果】本発明によれば、無機物質を含有する被
覆組成物により錠剤又は粒状物を被覆する際に、被覆後
の錠剤又は粒状物の汚れを防止し、高品質の被覆物を効
率的に製造でき、特に医薬品用被覆組成物、化粧品用被
覆組成物として有用である。また、被覆組成物における
無機物質の配合量は、汚れによる制約を受けることがな
いので、任意に設定することができる。According to the present invention, when coating tablets or granules with a coating composition containing an inorganic substance, stains on the tablets or granules after coating are prevented, and a high-quality coating is efficiently produced. Can be produced in particular, and is particularly useful as a coating composition for pharmaceuticals and a coating composition for cosmetics. In addition, the amount of the inorganic substance compounded in the coating composition is not restricted by stains and can be set arbitrarily.
【0023】[0023]
【実施例】以下、実施例を示し、本発明を具体的に説明
するが、本発明は下記の実施例に制限されるものではな
い。The present invention will be described below in more detail with reference to Examples, but the present invention is not limited to the following Examples.
【0024】[実施例1]ヒドロキシプロピルメチルセ
ルロース160g、ポリビニルピロリドン(分子量:約
40,000)16g及び酸化チタン16gを水に添加
し、常法により全量が1600gの被覆組成物の水分散
液を調製した。次いで、アセトアミノフェン、乳糖、結
晶セルロース及びステアリン酸マグネシウムからなり、
常法により製造された内径9mm、重量300mg/個
の円形素錠1000gをパンコーティング装置(フロイ
ント産業(株)製)に投入し、装置内を加温しながら上
記素錠を流動させると共に、上記被覆組成物の水分散液
を装置内にスプレーし、該水分散液中の水分を蒸発さ
せ、上記被覆組成物により被覆された錠剤を得た。ここ
で、上記被覆組成物の被覆量は素錠に対し5%とした。Example 1 160 g of hydroxypropylmethylcellulose, 16 g of polyvinylpyrrolidone (molecular weight: about 40,000) and 16 g of titanium oxide were added to water, and an aqueous dispersion of a coating composition having a total amount of 1600 g was prepared by a conventional method. did. Then consists of acetaminophen, lactose, crystalline cellulose and magnesium stearate,
1000 g of a circular plain tablet having an inner diameter of 9 mm and a weight of 300 mg / piece manufactured by a conventional method is put into a pan coating apparatus (manufactured by Freund Sangyo Co., Ltd.), and the plain tablet is fluidized while heating the inside of the apparatus, and An aqueous dispersion of the coating composition was sprayed into the apparatus to evaporate the water content in the aqueous dispersion to obtain tablets coated with the above coating composition. Here, the coating amount of the coating composition was 5% with respect to the uncoated tablet.
【0025】[実施例2]実施例1において、被覆組成
物の水分散液におけるポリビニルピロリドンの配合量を
0.8gに代えた以外は実施例1と同様にして上記被覆
組成物により被覆された錠剤を得た。なお、被覆量も実
施例1と同様とした。[Example 2] Coating was carried out with the above coating composition in the same manner as in Example 1 except that the amount of polyvinylpyrrolidone blended in the aqueous dispersion of the coating composition was changed to 0.8 g. A tablet was obtained. The coating amount was the same as in Example 1.
【0026】[実施例3]実施例1において、被覆組成
物の水分散液におけるポリビニルピロリドンの配合量を
32gに代えた以外は実施例1と同様にして上記被覆組
成物により被覆された錠剤を得た。なお、被覆量も実施
例1と同様とした。Example 3 A tablet coated with the above coating composition was prepared in the same manner as in Example 1 except that the amount of polyvinylpyrrolidone in the aqueous dispersion of the coating composition was changed to 32 g. Obtained. The coating amount was the same as in Example 1.
【0027】[実施例4]ヒドロキシプロピルメチルセ
ルロース105g、ポリビニルピロリドン(分子量:約
40,000)14g、酸化チタン14g及び軽質無水
ケイ酸21gを水に添加し、常法により全量が1500
gの被覆組成物の水分散液を調製した。次いで、アセト
アミノフェン、乳糖、結晶セルロース及びステアリン酸
マグネシウムからなり、常法により製造された長径17
mm、短径7mm、重量550mg/個のカプレット形
素錠800gをパンコーティング装置(フロイント産業
(株)製)に投入し、装置内を加温しながら上記素錠を
流動させると共に、上記被覆組成物の水分散液を装置内
にスプレーし、該水分散液中の水分を蒸発させ、上記被
覆組成物により被覆された錠剤を得た。ここで、上記被
覆組成物の被覆量は素錠に対し9.6%とした。Example 4 105 g of hydroxypropylmethyl cellulose, 14 g of polyvinylpyrrolidone (molecular weight: about 40,000), 14 g of titanium oxide and 21 g of light anhydrous silicic acid were added to water, and the total amount was 1500 according to a conventional method.
An aqueous dispersion of g coating composition was prepared. Next, the long diameter 17 composed of acetaminophen, lactose, crystalline cellulose and magnesium stearate and produced by a conventional method
mm, short diameter 7 mm, weight 550 mg / piece, 800 g of caplet type uncoated tablets are put into a pan coating device (manufactured by Freund Sangyo Co., Ltd.) and the uncoated tablets are fluidized while heating the inside of the device and the coating composition is A water dispersion of the product was sprayed into the apparatus to evaporate the water content in the water dispersion to obtain a tablet coated with the above coating composition. Here, the coating amount of the coating composition was 9.6% based on the uncoated tablets.
【0028】[実施例5]ヒドロキシプロピルメチルセ
ルロース160g、ポリビニルアルコール(重合度:約
1,000、けん化度:約88モル%)10g、酸化チ
タン16g及びタルク16gを水に添加し、常法により
全量が1600gの被覆組成物の水分散液を調製した。
次いで、アセトアミノフェン、乳糖、結晶セルロース及
びステアリン酸マグネシウムからなり、常法により製造
された内径9mm、重量300mg/個の円形素錠10
00gをパンコーティング装置(フロイント産業(株)
製)に投入し、装置内を加温しながら上記素錠を流動さ
せると共に、上記被覆組成物の水分散液を装置内にスプ
レーし、該水分散液中の水分を蒸発させ、上記被覆組成
物により被覆された錠剤を得た。ここで、上記被覆組成
物の被覆量は素錠に対し5%とした。Example 5 160 g of hydroxypropylmethyl cellulose, 10 g of polyvinyl alcohol (degree of polymerization: about 1,000, degree of saponification: about 88 mol%), 16 g of titanium oxide and 16 g of talc were added to water, and the whole amount was added by a conventional method. 1600 g of an aqueous dispersion of the coating composition was prepared.
Next, a round uncoated tablet 10 composed of acetaminophen, lactose, crystalline cellulose and magnesium stearate and manufactured by a conventional method, having an inner diameter of 9 mm and a weight of 300 mg / piece.
00g pan coating equipment (Freund Industrial Co., Ltd.)
Manufactured), while heating the inside of the device while heating the uncoated tablet, an aqueous dispersion of the coating composition is sprayed into the device to evaporate the water content in the aqueous dispersion, A tablet coated with the product was obtained. Here, the coating amount of the coating composition was 5% with respect to the uncoated tablet.
【0029】[実施例6]ヒドロキシプロピルメチルセ
ルロース160g、ポリビニルピロリドン(分子量:約
40,000)12g、ポリビニルアルコール(重合
度:約1,500、けん化度:約88モル%)4g及び
酸化チタン16gを水に添加し、常法により全量が16
00gの被覆組成物の水分散液を調製した。次いで、ア
セトアミノフェン、乳糖、結晶セルロース及びステアリ
ン酸マグネシウムからなり、常法により製造された内径
9mm、重量300mg/個の円形素錠1000gをパ
ンコーティング装置(フロイント産業(株)製)に投入
し、装置内を加温しながら上記素錠を流動させると共
に、上記被覆組成物の水分散液を装置内にスプレーし、
該水分散液中の水分を蒸発させ、上記被覆組成物により
被覆された錠剤を得た。ここで、上記被覆組成物の被覆
量は素錠に対し5%とした。Example 6 160 g of hydroxypropylmethylcellulose, 12 g of polyvinylpyrrolidone (molecular weight: about 40,000), 4 g of polyvinyl alcohol (polymerization degree: about 1,500, saponification degree: about 88 mol%) and 16 g of titanium oxide. It is added to water and the total amount is 16 according to the conventional method.
An aqueous dispersion of 00 g of the coating composition was prepared. Next, 1000 g of an uncoated round tablet composed of acetaminophen, lactose, crystalline cellulose and magnesium stearate and having an inner diameter of 9 mm and a weight of 300 mg / piece was put into a pan coating device (manufactured by Freund Sangyo Co., Ltd.). While flowing the uncoated tablet while heating the inside of the device, spray an aqueous dispersion of the coating composition into the device,
Moisture in the aqueous dispersion was evaporated to obtain tablets coated with the above coating composition. Here, the coating amount of the coating composition was 5% with respect to the uncoated tablet.
【0030】[実施例7]実施例6において、被覆組成
物の水分散液におけるポリビニルピロリドンの配合量を
4gに代え、ポリビニルアルコールの配合量を12gに
代えた以外は実施例6と同様にして上記被覆組成物によ
り被覆された錠剤を得た。なお、被覆量も実施例6と同
様とした。[Example 7] In the same manner as in Example 6 except that the amount of polyvinylpyrrolidone in the aqueous dispersion of the coating composition was changed to 4 g and the amount of polyvinyl alcohol was changed to 12 g in Example 6. A tablet coated with the above coating composition was obtained. The coating amount was the same as in Example 6.
【0031】[実施例8]アクアコート (商品名:旭
化成工業(株)製、エチルセルロース水性分散液)16
0g、ポリビニルピロリドン(分子量:約40,00
0)16g、酸化チタン60g及びクエン酸トリエチル
20gを水に添加し、常法により全量が500gの被覆
組成物の水分散液を調製した。次いで、粒径が500〜
710μmであるアセトアミノフェンを含有する球形状
の素粒状物500gを遠心流動型造粒コーティング装置
に投入し、装置内を加温しながら上記素粒状物を流動さ
せると共に、上記被覆組成物の水分散液を装置内の上記
素粒状物に対してスプレーし、該水分散液中の水分を蒸
発させ、上記被覆組成物により被覆されたアセトアミノ
フェン含有粒状物を得た。ここで、上記被覆組成物の被
覆量は素粒状物に対し30%とした。Example 8 Aqua Coat (trade name: Asahi Kasei Kogyo KK, ethyl cellulose aqueous dispersion) 16
0 g, polyvinylpyrrolidone (molecular weight: about 40,000)
0) 16 g, titanium oxide 60 g and triethyl citrate 20 g were added to water to prepare an aqueous dispersion of the coating composition having a total amount of 500 g by a conventional method. Next, the particle size is 500-
500 g of spherical elementary granules containing 710 μm acetaminophen was put into a centrifugal fluidization type granulation coating apparatus, the elementary granules were fluidized while heating the inside of the apparatus, and water of the coating composition was added. The dispersion was sprayed on the elementary particles in the apparatus to evaporate the water content in the aqueous dispersion to obtain acetaminophen-containing particles coated with the coating composition. Here, the coating amount of the coating composition was 30% with respect to the elementary particles.
【0032】[実施例9]ヒドロキシプロピルメチルセ
ルロース160g、ポリビニルピロリドン(分子量:約
40,000)16g及び酸化チタン16gを水に添加
し、プロペラ式撹拌により全量が1600gの被覆組成
物の水分散液を調製した。次いで、アセトアミノフェ
ン、乳糖、結晶セルロース及びステアリン酸マグネシウ
ムからなり、常法により製造された内径9mm、重量3
00mg/個の円形素錠1000gをパンコーティング
装置(フロイント産業(株)製)に投入し、装置内を加
温しながら上記素錠を流動させると共に、上記被覆組成
物の水分散液を装置内にスプレーし、該水分散液中の水
分を蒸発させ、上記被覆組成物により被覆された錠剤を
得た。ここで、上記被覆組成物の被覆量は素錠に対し5
%とした。Example 9 160 g of hydroxypropylmethylcellulose, 16 g of polyvinylpyrrolidone (molecular weight: about 40,000) and 16 g of titanium oxide were added to water, and a total amount of 1600 g of an aqueous dispersion of the coating composition was obtained by propeller stirring. Prepared. Next, consisting of acetaminophen, lactose, crystalline cellulose and magnesium stearate, manufactured by a conventional method, inner diameter 9 mm, weight 3
1000 mg of round uncoated tablets (00 mg / piece) were put into a pan coating device (manufactured by Freund Sangyo Co., Ltd.), the uncoated tablets were made to flow while heating the inside of the device, and an aqueous dispersion of the coating composition was placed in the device. Was sprayed on and the water in the aqueous dispersion was evaporated to obtain tablets coated with the above coating composition. Here, the coating amount of the coating composition is 5 with respect to the uncoated tablet.
%.
【0033】[比較例1]実施例3において、ポリビニ
ルピロリドン32gに代えて、ポリエチレングリコール
32gを配合した以外は実施例3と同様にして上記被覆
組成物により被覆された錠剤を得た。なお、被覆量も実
施例3と同様とした。Comparative Example 1 A tablet coated with the above coating composition was obtained in the same manner as in Example 3 except that 32 g of polyethylene glycol was added instead of 32 g of polyvinylpyrrolidone. The coating amount was the same as in Example 3.
【0034】[比較例2]実施例8において、ポリビニ
ルピロリドンを無配合とした以外は実施例8と同様にし
て上記被覆組成物により被覆された粒状物を得た。な
お、被覆量も実施例8と同様とした。Comparative Example 2 A granular material coated with the above coating composition was obtained in the same manner as in Example 8 except that polyvinylpyrrolidone was not added. The coating amount was the same as in Example 8.
【0035】[比較例3]実施例9において、ポリビニ
ルピロリドンを無配合とした以外は実施例9と同様にし
て上記被覆組成物により被覆された錠剤を得た。なお、
被覆量も実施例9と同様とした。[Comparative Example 3] A tablet coated with the above coating composition was obtained in the same manner as in Example 9 except that polyvinylpyrrolidone was not added. In addition,
The coating amount was the same as in Example 9.
【0036】上記実施例1〜9及び比較例1〜3で得ら
れた錠剤及び粒状物の肉眼観察を行い、下記の評価基準
により錠剤及び粒状物の表面の汚れを評価した。結果を
表1に示す。 <評価基準> (++); かなり汚れている (+) ; 汚れている (±) ; わずかに汚れている (−) ; 汚れていないThe tablets and granules obtained in the above Examples 1 to 9 and Comparative Examples 1 to 3 were visually observed, and the stains on the surfaces of the tablets and granules were evaluated according to the following evaluation criteria. The results are shown in Table 1. <Evaluation Criteria>(++); Very dirty (+); Stainable (±); Slightly soiled (-); Not soiled
【0037】[0037]
【表1】 [Table 1]
【0038】表1の結果によれば、本発明の被覆組成物
の場合、これらにより被覆を施された錠剤及び粒状物は
その表面に付着する汚れが抑制されているのに対し、ポ
リビニルピロリドン及びポリビニルアルコールのいずれ
も配合されていない被覆組成物の場合(比較例1〜
3)、これらにより被覆を施された錠剤及び粒状物は表
面に付着する汚れが抑制されていないことが認められ
る。According to the results shown in Table 1, in the case of the coating composition of the present invention, the tablets and granules coated with them have suppressed stains adhering to the surface thereof, whereas polyvinylpyrrolidone and In the case of a coating composition containing neither polyvinyl alcohol (Comparative Examples 1 to 1)
3), it is recognized that the tablets and granules coated with these do not suppress stains adhering to the surface.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 // A61K 9/30 A61K 9/30 9/50 9/50 J (A61K 47/28 47:02) (A61K 47/36 47:02) (A61K 47/38 47:02) (A61K 47/44 47:02) (72)発明者 小笠原 榮男 東京都墨田区本所1丁目3番7号 ライオ ン株式会社内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display location // A61K 9/30 A61K 9/30 9/50 9/50 J (A61K 47/28 47:02 ) (A61K 47/36 47:02) (A61K 47/38 47:02) (A61K 47/44 47:02) (72) Inventor Eikoo Ogasawara 1-3-7 Honjo, Sumida-ku, Tokyo Lion Shares In the company
Claims (4)
ン及び/又はポリビニルアルコールとを含有してなるこ
とを特徴とする被覆組成物。1. A coating composition comprising an inorganic substance, a coating agent and polyvinylpyrrolidone and / or polyvinyl alcohol.
ニルアルコールの配合量が無機物質に対して0.5〜2
500重量%である請求項1記載の被覆組成物。2. The blending amount of polyvinylpyrrolidone and / or polyvinyl alcohol is 0.5 to 2 with respect to the inorganic substance.
The coating composition according to claim 1, which is 500% by weight.
グネシウム、炭酸カルシウム、炭酸マグネシウム、二酸
化ケイ素、無水ケイ酸、ケイ酸アルミニウム、合成ヒド
ロタルサイト及び乾燥水酸化アルミニウムゲルから選ば
れる1種又は2種以上である請求項1又は2記載の被覆
組成物。3. An inorganic substance selected from the group consisting of titanium oxide, talc, magnesium oxide, calcium carbonate, magnesium carbonate, silicon dioxide, silicic acid anhydride, aluminum silicate, synthetic hydrotalcite and dry aluminum hydroxide gel. The coating composition according to claim 1 or 2, which comprises one or more kinds.
系被覆剤、多糖類系被覆剤及びセラックから選ばれる1
種又は2種以上である請求項1、2又は3記載の被覆組
成物。4. The coating material is selected from cellulosic coating material, acrylic coating material, polysaccharide coating material and shellac.
The coating composition according to claim 1, 2 or 3, which is one kind or two or more kinds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7176707A JPH092976A (en) | 1995-06-20 | 1995-06-20 | Coating composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7176707A JPH092976A (en) | 1995-06-20 | 1995-06-20 | Coating composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH092976A true JPH092976A (en) | 1997-01-07 |
Family
ID=16018355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7176707A Pending JPH092976A (en) | 1995-06-20 | 1995-06-20 | Coating composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH092976A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6383270B1 (en) * | 1999-07-14 | 2002-05-07 | N.T.S. Corporation | Film-forming composition and process for its production |
WO2007126039A1 (en) * | 2006-04-28 | 2007-11-08 | Shionogi & Co., Ltd. | Coated macrolide antibiotic preparation |
JP2011225576A (en) * | 1999-07-09 | 2011-11-10 | Bpsi Holdings Llc | Film coating and film coating composition based on polyvinyl alcohol |
US8303987B2 (en) | 2001-04-11 | 2012-11-06 | Novartis Ag | Pharmaceutical compositions comprising fluvastatin |
WO2014188728A1 (en) * | 2013-05-24 | 2014-11-27 | 持田製薬株式会社 | Film-coating composition |
JP2015124195A (en) * | 2013-12-27 | 2015-07-06 | 株式会社三和化学研究所 | Coating preparation containing miglitol |
JP2016135755A (en) * | 2015-01-15 | 2016-07-28 | 大原薬品工業株式会社 | Film coating formulation containing prodrug having medoxomil group |
WO2020004875A1 (en) * | 2018-06-29 | 2020-01-02 | 주식회사 스마코 | Film coating composition and tablet coated with same |
-
1995
- 1995-06-20 JP JP7176707A patent/JPH092976A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011225576A (en) * | 1999-07-09 | 2011-11-10 | Bpsi Holdings Llc | Film coating and film coating composition based on polyvinyl alcohol |
US6383270B1 (en) * | 1999-07-14 | 2002-05-07 | N.T.S. Corporation | Film-forming composition and process for its production |
US8303987B2 (en) | 2001-04-11 | 2012-11-06 | Novartis Ag | Pharmaceutical compositions comprising fluvastatin |
WO2007126039A1 (en) * | 2006-04-28 | 2007-11-08 | Shionogi & Co., Ltd. | Coated macrolide antibiotic preparation |
WO2014188728A1 (en) * | 2013-05-24 | 2014-11-27 | 持田製薬株式会社 | Film-coating composition |
JPWO2014188728A1 (en) * | 2013-05-24 | 2017-02-23 | 持田製薬株式会社 | Film coating composition |
JP2015124195A (en) * | 2013-12-27 | 2015-07-06 | 株式会社三和化学研究所 | Coating preparation containing miglitol |
JP2016135755A (en) * | 2015-01-15 | 2016-07-28 | 大原薬品工業株式会社 | Film coating formulation containing prodrug having medoxomil group |
WO2020004875A1 (en) * | 2018-06-29 | 2020-01-02 | 주식회사 스마코 | Film coating composition and tablet coated with same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2540308C (en) | Drug coating providing high drug loading and methods for providing the same | |
KR102164600B1 (en) | Delayed release film coatings containing calcium silicate and substrates coated therewith | |
AU698360B2 (en) | Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application | |
JP4868695B2 (en) | Oral preparation with good disintegration | |
US4970081A (en) | Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith | |
JPS5942325A (en) | Composition for coating and pharmaceutical preparation of coating | |
JPH092976A (en) | Coating composition | |
JP4926495B2 (en) | Coated granules containing ibuprofen | |
JP2841267B2 (en) | Ibuprofen-containing granules | |
JP2001151672A (en) | Water-based film-coating agent and solid preparation for oral administration | |
JPWO2011043370A1 (en) | Coating film, granule and tablet using the same | |
JP2002316928A (en) | Coated tablet and method for preventing peeling of coated tablet | |
JP4716063B2 (en) | Unpleasant taste masking particles and oral preparations containing the same | |
JPH093348A (en) | Method for preventing discoloration of colorant, and colorant composition | |
JP2012140335A (en) | Unpleasant taste masking particle, and oral formulation containing the same | |
FR2738833A1 (en) | FILMOGENIC COMPOSITION FOR TASTE MASKING INTENDED FOR COATING INHERENT SOLID FORMS SUCH AS PHARMACEUTICAL TABLETS IN PARTICULAR | |
JPH115736A (en) | Tablets containing ibuprofen | |
JP3718398B2 (en) | Film coating agent and oral solid preparation | |
AU6224699A (en) | Taste masking coating compositions | |
JP2002003366A (en) | Aqueous coating composition for solid medicine | |
JP2001139495A (en) | Film-coating agent and oral solid preparation | |
JP2021521177A (en) | Acidification coating and disintegration resistant substrate coated thereby | |
WO2022181569A1 (en) | Orally disintegrating composition, capsule, film-coated tablet, film preparation, and method for improving ease of oral disintegration | |
JP2006256975A (en) | Guaifenesin-containing preparations | |
JP5146859B2 (en) | Controlled release formulation coated with aqueous dispersion of acrylic polymer and method thereof |